About 2.2K results
Any time
Open links in new tab
Urology & Nephrology News, Treatment Studies
WEBA proposed 2025 Physician Fee Schedule conversion factor of $32.36 represents a 2.8% decrease from 2024.
Prostate Cancer Genetic Testing Lagging Despite Benefits
News Archive - Renal and Urology News
Darolutamide Plus ADT Beneficial in mHSPC Without Docetaxel
Nivolumab Plus Ipilimumab Treats Patients With mCRPC and …
Prostate Cancer ADT Tied to Risk Factors for Cardiovascular Events
Jardiance Approved for Adults With Chronic Kidney Disease
Novel Ultrasound Procedures Promise Improved Kidney Stone Care
Dual Androgen Receptor Ligand Degrader, Antagonist Shows …
Study: Ibuprofen Found Safest NSAID for the Kidney